Skip to Main Content

Author Details

Jessica Leonard
Oregon Health & Science University
2015
22
11
PMIDPaper TitleJournal TitlePublished Year
34081042PSEUDOPANUVEITIS AS A HARBINGER FOR SYSTEMIC LEUKEMIA RECURRENCE.Retin Cases Brief Rep2023
37311155Using Measurable Residual Disease to Optimize Management of AML, ALL, and Chronic Myeloid Leukemia.Am Soc Clin Oncol Educ Book2023
37196642Next-generation sequencing-based MRD in adults with ALL undergoing hematopoietic cell transplantation.Blood Adv2023
36441905Comparison and validation of the 2022 European LeukemiaNet guidelines in acute myeloid leukemia.Blood Adv2023
36130863SOHO State of the Art Updates and Next Questions: Measurable Residual Disease in Acute Lymphoblastic Leukemia - Optimization and Innovation in 2022 and Beyond.Clin Lymphoma Myeloma Leuk2022
35868306Integrative analysis of drug response and clinical outcome in acute myeloid leukemia.Cancer Cell2022
32898857Concomitant use of a dual Src/ABL kinase inhibitor eliminates the in vitro efficacy of blinatumomab against Ph+ ALL.Blood2021
33901720Engrafted Donor-Derived Clonal Hematopoiesis after Allogenic Hematopoietic Cell Transplantation is Associated with Chronic Graft-versus-Host Disease Requiring Immunosuppressive Therapy, but no Adverse Impact on Overall Survival or Relapse.Transplant Cell Ther2021
33593877Venetoclax and Navitoclax in Combination with Chemotherapy in Patients with Relapsed or Refractory Acute Lymphoblastic Leukemia and Lymphoblastic Lymphoma.Cancer Discov2021
33961341Graft-versus-host disease after liver transplantation is associated with bone marrow failure, hemophagocytosis, and DNMT3A mutations.Am J Transplant2021
34233449Aurora A kinase as a target for therapy in <i>TCF3-HLF</i> rearranged acute lymphoblastic leukemia.Haematologica2021
31980503Functional characterization of two rare BCR-FGFR1<sup>+</sup> leukemias.Cold Spring Harb Mol Case Stud2020
31145495The combination of NPM1, DNMT3A, and IDH1/2 mutations leads to inferior overall survival in AML.Am J Hematol2019
30836091Allogeneic transplantation outcomes amongst a contemporary cohort of high-risk myelodysplastic syndrome and acute myeloid leukemia patients aged â¿¥70 years.Hematol Oncol Stem Cell Ther2019
29199519Outcomes of DA-EPOCH-R induction plus autologous transplant consolidation for double hit lymphoma.Leuk Lymphoma2018
30008035Reduced Intensity Conditioning Allogeneic Hematopoietic Stem Cell Transplantation for Acute Lymphoblastic Leukemia; Current Evidence, and Improving Outcomes Going Forward.Curr Hematol Malig Rep2018
30333627Functional genomic landscape of acute myeloid leukaemia.Nature2018
29222234Progress in adult ALL: incorporation of new agents to frontline treatment.Hematology Am Soc Hematol Educ Program2017
27036514Functional and genetic screening of acute myeloid leukemia associated with mediastinal germ cell tumor identifies MEK inhibitor as an active clinical agent.J Hematol Oncol2016
27582059Targeting BCL-2 and ABL/LYN in Philadelphia chromosome-positive acute lymphoblastic leukemia.Sci Transl Med2016
27634020The Persistence of Minimal Residual Disease in Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia: We Know It's Bad, Now What?Biol Blood Marrow Transplant2016
25961774Chronic GvHD-associated serositis and pericarditis.Bone Marrow Transplant2015
  • 1 - 22 of 22

Recommended Authors

Thai Hoa Tran
Universite de Montreal
Career Start Year 2013
Number of shared co-authors 9
Shalin Kothari
Yale University
Career Start Year 2013
Number of shared co-authors 0
Thomas K??hnke
Cancer Institute, Stanford University School of Medicine
Career Start Year 2008
Number of shared co-authors 6
Friedrich St??lzel
University Hospital TU Dresden
Career Start Year 2008
Number of shared co-authors 3
Kara L Davis
Stanford University School of Medicine
Career Start Year 2008
Number of shared co-authors 2
Amanda Winters
University of Colorado School of Medicine
Career Start Year 2008
Number of shared co-authors 4
Paulo Vidal Campregher
Hospital Israelita Albert Einstein
Career Start Year 2007
Number of shared co-authors 0
Courtney D DiNardo
UT MD Anderson Cancer Center
Career Start Year 2007
Number of shared co-authors 15
Rashmi Kanagal-Shamanna
The University of Texas MD Anderson Cancer Center
Career Start Year 2006
Number of shared co-authors 4
Yana Pikman
Dana Farber Cancer Institute
Career Start Year 2005
Number of shared co-authors 5
Marlise R Luskin
Dana-Farber Cancer Institute
Career Start Year 2005
Number of shared co-authors 24
Thomas Cluzeau
Universite Nice Cote d'azur, CHU de Nice
Career Start Year 2005
Number of shared co-authors 1
Emmanuelle Clappier
Saint-Louis Hospital
Career Start Year 2005
Number of shared co-authors 1
Patrick Brown
Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University
Career Start Year 2004
Number of shared co-authors 8
Emmanuel Raffoux
Universite Paris Diderot
Career Start Year 1998
Number of shared co-authors 1
Guillermo Garcia-Manero
MD Anderson Cancer Center
Career Start Year 1997
Number of shared co-authors 32
Farhad Ravandi
University of Texas M.D. Anderson Cancer Center
Career Start Year 1997
Number of shared co-authors 26
David A Rizzieri
Duke University Medical Center
Career Start Year 1995
Number of shared co-authors 12
Meenakshi Devidas
St Jude Children's Research Hospital
Career Start Year 1993
Number of shared co-authors 7
Bijal Shah
Moffitt Cancer Center
Career Start Year 1992
Number of shared co-authors 5
Gautam Borthakur
MD Anderson Cancer Center
Career Start Year 1992
Number of shared co-authors 22
Jorge Cortes
Georgia Cancer Center
Career Start Year 1991
Number of shared co-authors 41
Daniel J DeAngelo
Dana-Farber Cancer Institute
Career Start Year 1989
Number of shared co-authors 28
Jerald P Radich
Fred Hutchinson Cancer Center
Career Start Year 1989
Number of shared co-authors 23
Sima Jeha
St. Jude Children's Research Hospital
Career Start Year 1988
Number of shared co-authors 5
Soheil Meshinchi
Fred Hutchinson Cancer Research Centre
Career Start Year 1987
Number of shared co-authors 17
Richard M Stone
Dana Farber Cancer Institute
Career Start Year 1986
Number of shared co-authors 34
Herv?? Dombret
Institut de Recherche Saint-Louis, Universite de Paris
Career Start Year 1984
Number of shared co-authors 5
Martin S Tallman
Memorial Sloan-Kettering Cancer Center
Career Start Year 1982
Number of shared co-authors 17
Hagop Kantarjian
The University of Texas MD Anderson Cancer Center
Career Start Year 1982
Number of shared co-authors 36

Collaborators

Brian J Druker
Oregon Health & Science University
Co-authored papers 8
Brandon Hayes-Lattin
Knight Cancer Institute, Oregon Health and Science University
Co-authored papers 8
Elie Traer
Oregon Health & Science University
Co-authored papers 8
Jennifer Dunlap
Oregon Health & Science University
Co-authored papers 7
Jeffrey W Tyner
Oregon Health & Science University School of Medicine
Co-authored papers 7
Richard T Maziarz
Oregon Health & Science University
Co-authored papers 6
Laura F Newell
Oregon Health and Science University
Co-authored papers 5
Bill H Chang
Oregon Health and Science University
Co-authored papers 5
Marc M Loriaux
Knight Cancer Institute, Oregon Health & Science University
Co-authored papers 4
Richard D Press
Oregon Health and Science University
Co-authored papers 4
Christopher A Eide
Knight Cancer Institute, Oregon Health & Science University
Co-authored papers 4
Rachel J Cook
Oregon Health and Science University
Co-authored papers 4
Gabrielle Meyers
Oregon Health and Science University
Co-authored papers 4
Nicola Long
Oregon Health and Science University
Co-authored papers 3
Daniel Bottomly
Knight Cancer Institute, Oregon Health & Science University
Co-authored papers 3
Beth Wilmot
Knight Cancer Institute, Oregon Health & Science University
Co-authored papers 3
Michelle Degnin
Knight Cancer Institute, Oregon Health & Science University
Co-authored papers 3
Shannon K McWeeney
Oregon Health & Science University, University of California Berkeley
Co-authored papers 3
Uma Borate
The Ohio State University
Co-authored papers 3
Ronan Swords
Oregon Health and Science University
Co-authored papers 3
Stephen E Spurgeon
Knight Cancer Institute, Oregon Health and Science University
Co-authored papers 3
Kim-Hien T Dao
Astex Pharmaceuticals
Co-authored papers 3
Cristina E Tognon
Knight Cancer Institute, Oregon Health & Science University
Co-authored papers 3
Guang Fan
Oregon Health and Science University
Co-authored papers 3
Joelle Wolf
Knight Cancer Institute, Oregon Health & Science University
Co-authored papers 3
Cody Coblentz
Knight Cancer Institute, Oregon Health & Science University
Co-authored papers 2
Aurora S Blucher
Knight Cancer Institute, Oregon Health Sciences University
Co-authored papers 2
Melissa L Abel
National Cancer Institute, National Institutes of Health
Co-authored papers 2
Justin M Watts
University of Miami, Sylvester Comprehensive Cancer Center
Co-authored papers 2
Charles G Mullighan
St Jude Children's Research Hospital
Co-authored papers 2
Release 1.2